Matinas Biopharma Holdings Stock Statistic Functions Linear Regression Slope
| MTNB Stock | USD 1.56 0.08 5.41% |
| Symbol |
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Linear Regression Slope is the rate of change in Matinas BioPharma price series over its benchmark or peer price series.
Matinas BioPharma Technical Analysis Modules
Most technical analysis of Matinas BioPharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Matinas from various momentum indicators to cycle indicators. When you analyze Matinas charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Matinas BioPharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Matinas BioPharma Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Matinas BioPharma Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Matinas Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Matinas BioPharma's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Matinas BioPharma's intrinsic value. In addition to deriving basic predictive indicators for Matinas BioPharma, we also check how macroeconomic factors affect Matinas BioPharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2024 | 2025 (projected) | Dividend Yield | 4.57 | 4.34 | Price To Sales Ratio | 38.57 | 36.64 |
Align your values with your investing style
In addition to having Matinas BioPharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested over 30 shares | |
 | Hedge Favorites Invested over 30 shares | |
 | Business Services Invested few shares | |
 | Driverless Cars Invested over 50 shares | |
 | Chemicals Invested over 40 shares | |
 | Cash Cows Invested few shares | |
 | High Dividend Yield ETFs Invested over 10K shares | |
| Broad Equity ETFs Invested over 100 shares | |
| Size And Style ETFs Invested over 100 shares | |
| Small Cap ETFs Invested over 90 shares | |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Matinas BioPharma Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Matinas BioPharma. If investors know Matinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Matinas BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Matinas BioPharma is measured differently than its book value, which is the value of Matinas that is recorded on the company's balance sheet. Investors also form their own opinion of Matinas BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Matinas BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Matinas BioPharma's market value can be influenced by many factors that don't directly affect Matinas BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Matinas BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Matinas BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Matinas BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.